Mauricio Concha is a Neurology physician affiliated with Coastal Behavioral Healthcare. OpenAlex indexes 84 publications with 6,922 citations (h-index 32); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2881 Hyde Park St
Sarasota, FL 342393228
Telephone
941-906-7155Provider last certified this registry record 16 Oct 2024.
Clinical trials
- Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours
Sponsor: Genervon Biopharmaceuticals, LLC
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year202531 payments$42,349openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20251 payment
- Amgen Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
74.6%Cholinesterase Inhibitor21.8%Donepezil Hcl94%Donepezil Hcl Odt7%Part D<11 patientsSSRI7.7%Escitalopram Oxalate37%Sertraline Hcl34%Trazodone Hcl29%Part D<11 patients+ 12 more classes in this area
Cardiovascular
20.4%Statin7.2%Atorvastatin Calcium75%Rosuvastatin Calcium25%Part D<11 patientsBeta blocker4.7%Metoprolol Succinate53%Nadolol47%Part D<11 patients+ 4 more classes in this area
Musculoskeletal
1.5%Central alpha-2 Adrenergic Agonist1.5%Tizanidine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke
New England Journal of Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”